手术与药物治疗对Graves病心血管表现的影响
该回顾性研究纳入151例伴有心血管合并症的Graves病患者,比较手术(甲状腺全切)与药物治疗的心血管结局。手术组高血压缓解率44.7% vs 药物组18%(P=.03),快速性心律失常改善率85.9% vs 66%(P=.01),所有心血管表现改善率69% vs 42.6%(P<.01)。结论认为手术可显著且快速改善心血管表现。
要点
- 手术组高血压缓解率44.7%,显著高于药物组18%(P=.03)。
- 手术组快速性心律失常改善率85.9%,高于药物组66%(P=.01)。
- 手术组所有心血管表现改善率69%,高于药物组42.6%(P<.01)。
核心结论
- 手术治疗对Graves病患者的高血压、快速性心律失常和心力衰竭等心血管表现有显著且快速的临床改善。
- 伴有已知心血管表现的Graves病患者应考虑并推荐手术治疗。
研究设计与样本
- 回顾性研究,纳入151例伴有心血管合并症的Graves病患者,其中69例(45.6%)行甲状腺全切术,82例(54.3%)接受药物治疗。
- 分析比较手术组与药物组的围术期生化及心血管结局。
主要发现
- 手术组高血压缓解率为44.7%,药物组为18%(P=.03)。
- 手术组快速性心律失常(包括心房颤动和心动过速)改善率为85.9%,药物组为66%(P=.01)。
- 随访期间手术组所有心血管表现(高血压、快速性心律失常、心力衰竭)改善率为69%,药物组为42.6%(P<.01)。
临床怎么用
- 对于伴有心血管表现(如高血压、快速性心律失常、心力衰竭)的Graves病患者,可将甲状腺全切术作为推荐治疗选项之一。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Graves disease is well known to have multiple adverse effects on the cardiovascular system. We compared the cardiovascular outcomes after surgical intervention versus medical treatment in patients with Graves disease. METHODS: We performed a retrospective study of all Graves disease patients with a cardiovascular comorbidity who underwent either surgical or medical management (N = 151). Perioperative biochemical and cardiovascular outcomes from the surgical versus the medical groups were analyzed. RESULTS: Of 151 patients, 69 (45.6%) patients underwent total thyroidectomy and 82 (54.3%) patients received medical treatment. Hypertension resolved in 44.7% of the patients from the surgical group vs 18% in the medical group (P = .03). Tachyarrhythmias, including atrial fibrillation and tachycardia, improved in 85.9% of patients in the surgical group vs 66% in the medical group (P = .01). All cardiovascular manifestations examined, hypertension, tachyarrhythmias, and heart failure, improved in 69% of patients in the surgical group and 42.6% of patients in the medical group during the follow-up period (P < .01). CONCLUSION: Surgical treatment offers a significant and rapid clinical improvement of cardiovascular manifestations in Graves disease patients, such as hypertension, tachyarrhythmias, and heart failure. Surgery should be considered and recommended in Graves disease patients with known cardiovascular manifestations.
引用
- Elnahla A, Attia AS, Khadra HS, et al. Impact of surgery versus medical management on cardiovascular manifestations in Graves disease. Surgery. 2020. PMID: 32402541. doi:10.1016/j.surg.2020.03.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。